Search - tctmd.com

Displaying 361 - 380 of 465

Presentation TCT 2014

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

Presentation

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Presenter: A. Persue

May 12, 2014

$Renal Denervation for Hypertension Refractory to Renal Artery Stenting$

Presentation

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

Presenter: Yvonne Bausback

May 02, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

Presentation Fellows 2014

Renal Artery Intervention and Denervation for Resistant Hypertension

Presenter: Duane Pinto

April 14, 2014

Presentation

Why is there So Much Excitement Over Renal Denervation?

Presenter: Michael R. Jaff

December 01, 2013

Presentation

What We Don’t Know, But Need to Know About Renal Denervation

Presenter: Krishna Rocha-Singh

December 01, 2013

Presentation

Renal Denervation - Cardiosonic Update: The Hypertension Specialist’s Perspective

Presenter: Mel Lobo

December 01, 2013

Presentation

OneShot™ Renal Denervation System: Clinical Program Update

Presenter: Eberhard Grube

December 01, 2013

Presentation

Establishing Evidence in the Field of Renal Denervation: The EnligHTN Clinical Evidence Series

Presenter: Mel Lobo

December 01, 2013

Presentation

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Presenter: Eli Lev

December 01, 2013

Presentation

Attack on the Sympathetic System: Locations for Denervation Besides the Renal Artery

Presenter: William A. Gray

December 01, 2013

Presentation TCT 2013

Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case

Presenter: Felix Mahfoud

October 31, 2013

Presentation TCT 2013

Renal Denervation with the ReCor Paradise Device: One Simple and One Not-So-Simple Case

Presenter: Joost Daemen

October 31, 2013

Presentation TCT 2013

Renal Denervation with the Medtronic Symplicity Devices: One Simple and One Not-So-Simple Case

Presenter: Robert Whitbourn

October 31, 2013

Presentation TCT 2013

Renal Denervation with the Boston Scientific Vessix Device: One Simple and One Not-So-Simple Case

Presenter: Joost Daemen

October 31, 2013

Presentation TCT 2013

Renal Denervation with the Allegro/Iberis Device: One Simple and One Not-So-Simple Case

Presenter: Xiongjing Jiang

October 31, 2013

Advertisement

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Renal Artery Intervention and Denervation for Resistant Hypertension

Why is there So Much Excitement Over Renal Denervation?

What We Don’t Know, But Need to Know About Renal Denervation

Renal Denervation - Cardiosonic Update: The Hypertension Specialist’s Perspective

OneShot™ Renal Denervation System: Clinical Program Update

Establishing Evidence in the Field of Renal Denervation: The EnligHTN Clinical Evidence Series

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Attack on the Sympathetic System: Locations for Denervation Besides the Renal Artery

Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case

Renal Denervation with the ReCor Paradise Device: One Simple and One Not-So-Simple Case

Renal Denervation with the Medtronic Symplicity Devices: One Simple and One Not-So-Simple Case

Renal Denervation with the Boston Scientific Vessix Device: One Simple and One Not-So-Simple Case

Renal Denervation with the Allegro/Iberis Device: One Simple and One Not-So-Simple Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content